| NETs | neutrophil extracellular traps |
| DAMPs | damage-associated molecular patterns |
| oxLDL | oxidized low-density lipoprotein |
| CVD | cardiovascular disease |
| MPO | myeloperoxidase |
| ROS | reactive oxygen species |
| NE | neutrophil elastase |
| PMNs | polymorphonuclear leukocytes |
| PMA | phorbol myristate acetate |
| PAD4 | peptidylarginine deiminase 4 |
| MS | mass spectrometry |
| PG | phenylglyoxal |
| ADAMTS13 | a disintegrin-like and metalloproteinase with thrombospondin type 1 motif 13 |
| vWF | von Willebrand factor |
| ECs | endothelial cells |
| TLRs | toll-like receptors |
| RAGE | receptor for advanced glycation end products |
| HMGB1 | high-mobility group box 1 |
| SLE | systemic lupus erythematosus |
| SMCs | smooth muscle cells |
| HDL | high-density lipoprotein |
| EndMT | endothelial-to-mesenchymal transition |
| PLs | phospholipids |
| Lp-PLA2 | lipoprotein-associated phospholipase A2 |
| E-LDL | enzymatically-modified LDL |
| LDL(-) | electronegative LDL |
| MMP | matrix metalloproteinase |
| LOX-1 | lectin-like oxLDL receptor 1 |
| ICAM-1 | intercellular adhesion molecule-1 |
| TGs | triglycerides |
| AMI | acute myocardial infarction |
| oxPC | oxidized phosphatidylcholine |
| sdLDL | small dense LDL |
| S1P | sphingosine-1-phosphate |
| LDN | low-density neutrophil |
| GPI | glycoprotein I |